Navigation Links
Novartis files application with FDA for Zometa

Novartis Pharmaceuticals has submitted an application to the Food and Drug Administration, seeking marketing authorization for Zometa in the treatment of bone complications associated with a broad range of tumor types. These include prostate and lung cancer, for which no bisphosphonate therapy is currently approved. The spread of cancerous cells from the original tumor to the bone, can lead to serious complications called skeletal related events like fractures, compression of the spinal cord, severe bone pain and hypercalcemia.//

Zometa is a new generation intravenous bisphosphonate that was approved by the FDA just two weeks ago (20 August 2001) for the treatment of hypercalcemia of malignancy (HCM), the most common life-threatening metabolic complication of cancer. To date, Novartis has received marketing clearances for Zometa in the treatment of hypercalcemia of malignancy (HCM) in more than 30 countries.

"Bone complications can be extremely debilitating to cancer patients, and seriously impact their day to day activities. Zometa offers these patients an effective treatment with a convenient 15-minute infusion time. Novartis is pleased to bring forward another drug that will help make a marked difference in the lives of cancer patients and their families" said David Epstein, President, Novartis Oncology.

Three trials have been successfully conducted, evaluating more than 3,000 patients. This is the largest set of clinical trials ever conducted to evaluate the efficacy and tolerability of bisphosphonates in treating bone complications.


'"/>




Page: 1

Related medicine news :

1. Canine Painkiller unveiled by Novartis
2. Glivec the hot cancer drug from Novartis
3. Zometa [Novartis Drug] For Treatment Of Paget’s Diseas
4. Novartis MS Drug Shows Promising Results
5. Bird-flu Vaccine Adjuvant Contract Goes to Novartis
6. Drop Patent Petition, Activists Ask Novartis
7. E.U. Panel Backs Novartis Mock-up Pandemic Flu Vaccine
8. Indian Court Refers Novartis Plea for Patent on Anti-cancer Drug to a Separate Board
9. Novartis Gleevec Found Effective in Treating Gastro-intestinal Tumors
10. Novartis Drug Diovan Shows Superior Benefits
11. Unfavourable Lipid-Lipoprotein profiles in older adults has been linked to abdominal visceral fat
Post Your Comments:
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...oldiers who are suffering from mental illness afte...sked to wait 18 months or longer for treatment// f...at the figures released by British Ministry of Def... women have been treated for mental health conditi...
...additives which are banned from food and drinks ar...ildren. This was disclosed by a survey// conducted...were studied, only one did not have any harmful ad...n these drugs cause diarrhea, skin rashes, stomach...
... of food industry representatives in Sydney has co...ans fats from their products//. The move follows s...ies. The industry in Australia is also coming und...to deal with the issue, or else face regulatory re...
...g the causes of heart disease as a thousand piece ...University of Pittsburgh//, have admitted to putti...gist of her study, which attempted to connect gene...hat anger and depression could be genetic. Study...
Other Medicine News:Health News:Banned Additives Found in Children’s Medicine 2
(Date:10/7/2008)...the efficacy of new device for detecting polyps th...noscopy, ORLANDO, Fla., Oct. 7 /- At...cientific Meeting in Orlando (ACG 2008), renowned,...sults from a,multi-institutional clinical study th...oscope(R), a new device that is designed to improv...
(Date:10/7/2008)...arazotide Acetate Prevented Immunologic Changes In...eliac Disease, Additional Data Indicates Potential... Fla., Oct. 7 /- Alba Therapeutics Co...ies this week at the American,College of Gastroent... from,study CLIN 1001-004, the first Phase IIa tri...
(Date:10/7/2008)...Presented Today at ACG Annual Scientific Meeting -... Ironwood,Pharmaceuticals, Inc. (formerly Microbia...) today announced the presentation of results from...nd efficacy in 420 patients with,irritable bowel s... data,indicates that once- daily oral dosing of li...
(Date:10/7/2008)...spective Randomized Placebo-Controlled Phase II St...ved Overall Survival., MOUNTAIN VIEW, California,...as now evaluated the mature Phase II data from the...STVAC(TM) that had been,obtained as part of the re...r Institute (NCI) in the US., The results from th...
Breaking Medicine Technology:National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Nanorings 2410 2/ 1Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston 13521 1Inaugural Bowen Foundation Run Walk to Fight Autism in Maryland Set for Saturday March 29 13516 1Inaugural Bowen Foundation Run Walk to Fight Autism in Maryland Set for Saturday March 29 13516 2NBA All Star Alonzo Mourning is at the Top of his Game When It Comes to Spreading the Word About Chronic Kidney Disease 3727 1NBA All Star Alonzo Mourning is at the Top of his Game When It Comes to Spreading the Word About Chronic Kidney Disease 3727 2NBA All Star Alonzo Mourning is at the Top of his Game When It Comes to Spreading the Word About Chronic Kidney Disease 3727 3
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: